Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis?

Publication ,  Journal Article
Karanlik, H; Ozgur, I; Simsek, S; Fathalizadeh, A; Tukenmez, M; Sahin, D; Dursun, M; Kurul, S
Published in: Breast Care
December 2, 2014

Background: The aim of this study is to compare the clinical course of idiopathic granulomatous mastitis (IGM) treated with low-dose oral corticosteroid therapy alone as opposed to treatment with low-dose corticosteroid therapy followed by surgery. Patients and Methods: 37 patients were treated with an approach that consisted of methylprednisolone at a dose of 0.5 mg/kg/day followed by wide excision, and 23 patients were treated with an approach that consisted only of methylprednisolone. The treatment efficacy was compared between the two groups. Results: Clinical and radiological regression was reported in all patients with steroid therapy, and the regression rate had a median of 75% (25-100%). No recurrence was observed in patients who were treated with wide surgical excision after steroid therapy during the median follow-up period of 38 (22-78) months. The control group of 23 patients was treated only with steroid therapy, and 7 (30%) of these patients experienced recurrence in the follow-up period (p < 0.001). Conclusions: Steroid therapy was effective in the treatment of IGM by reducing the lesion size and extent. With regard to the current treatment options available for IGM, surgical excision after steroid therapy seems the better treatment option compared to steroid therapy without surgical excision. This treatment sequence reduces the rate of recurrence.

Published In

Breast Care

DOI

EISSN

1661-3805

ISSN

1661-3791

Publication Date

December 2, 2014

Volume

9

Issue

5

Start / End Page

338 / 342

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Karanlik, H., Ozgur, I., Simsek, S., Fathalizadeh, A., Tukenmez, M., Sahin, D., … Kurul, S. (2014). Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis? Breast Care, 9(5), 338–342. https://doi.org/10.1159/000366437
Karanlik, H., I. Ozgur, S. Simsek, A. Fathalizadeh, M. Tukenmez, D. Sahin, M. Dursun, and S. Kurul. “Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis?Breast Care 9, no. 5 (December 2, 2014): 338–42. https://doi.org/10.1159/000366437.
Karanlik H, Ozgur I, Simsek S, Fathalizadeh A, Tukenmez M, Sahin D, et al. Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis? Breast Care. 2014 Dec 2;9(5):338–42.
Karanlik, H., et al. “Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis?Breast Care, vol. 9, no. 5, Dec. 2014, pp. 338–42. Scopus, doi:10.1159/000366437.
Karanlik H, Ozgur I, Simsek S, Fathalizadeh A, Tukenmez M, Sahin D, Dursun M, Kurul S. Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis? Breast Care. 2014 Dec 2;9(5):338–342.
Journal cover image

Published In

Breast Care

DOI

EISSN

1661-3805

ISSN

1661-3791

Publication Date

December 2, 2014

Volume

9

Issue

5

Start / End Page

338 / 342

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1103 Clinical Sciences